NCT06671691View on ClinicalTrials.gov

A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I Trial

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2027

Conditions
Breast Cancer Early Stage Breast Cancer (Stage 1-3)SBRT
Interventions
RADIATION

SBRT level I

20Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique

RADIATION

SBRT level II

23Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique

RADIATION

SBRT level III

26Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique

RADIATION

SBRT level IV

28Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique

RADIATION

SBRT level V

30Gy in 1 fraction will be tested on the tumor using stereotactic body radiotherapy (SBRT) technique

Trial Locations (1)

07120

Hospital Universitario Son Espases, Palma

All Listed Sponsors
lead

Universitat de les Illes Balears

OTHER